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Mycobacterium ulcerans is the etiologic agent of Buruli ulcer (BU), an emerging tropical skin disease. Virulent
M. ulcerans secretes mycolactone, a cytotoxic exotoxin with a key pathogenic role. M. ulcerans in biopsy
specimens has been described as an extracellular bacillus. In vitro assays have suggested a mycolactone-
induced inhibition ofM. ulcerans uptake by macrophages in which its proliferation has not been demonstrated.
Therefore, and uniquely for a mycobacterium, M. ulcerans has been classified as an extracellular pathogen. In
specimens from patients and in mouse footpad lesions, extracellular bacilli were concentrated in central
necrotic acellular areas; however, we found bacilli within macrophages in surrounding inflammatory infil-
trates. We demonstrated that mycolactone-producing M. ulcerans isolates are efficiently phagocytosed by
murine macrophages, indicating that the extracellular location of M. ulcerans is not a result of inhibition of
phagocytosis. Additionally, we found that M. ulcerans multiplies inside cultured mouse macrophages when low
multiplicities of infection are used to prevent early mycolactone-associated cytotoxicity. Following the prolif-
eration phase within macrophages, M. ulcerans induces the lysis of the infected host cells, becoming extracel-
lular. Our data show that M. ulcerans, like M. tuberculosis, is an intracellular parasite with phases of intram-
acrophage and extracellular multiplication. The occurrence of an intramacrophage phase is in accordance with
the development of cell-mediated and delayed-type hypersensitivity responses in BU patients.
Mycobacterium ulcerans is the etiologic agent of Buruli ulcer
(BU), an emerging, devastating, difficult-to-treat skin disease
reported in many countries, mostly in tropical areas (16), and
BU has become the third most common mycobacterial infec-
tion in humans after tuberculosis and leprosy. BU assumes
various nonulcerative clinical forms that can progress to ulcers.
M. ulcerans (26, 41, 47, 59), M. tuberculosis (24, 38, 42), M.
marinum (25, 57), and M. haemophilum (23) are known to have
cytotoxic activity, M. ulcerans being the most cytotoxic of all
known mycobacteria. The M. ulcerans toxin is a mycolactone, a
unique polyketide lipid exotoxin that has a potent destructive
activity for cells that provokes the extensive necrotic lesions
characteristic of BU (26). Mycolactone is considered to be the
major virulence factor of this pathogen (1, 26, 41).
Intracellular parasites are defined on the basis of their life-
styles in the infected hosts and of the types of immune re-
sponses elicited (7, 37): they live and multiply predominantly
within host cells, typically macrophages, and therefore are able
to survive and grow within cultured macrophages. The host
immune response against intramacrophage parasites involves
mechanisms of cell-mediated immunity (CMI) accompanied by
delayed-type hypersensitivity (DTH).
Genetic analysis places M. ulcerans very close to M. marinum
and M. tuberculosis (71), two species of mycobacteria that are
typical intracellular parasites that grow within macrophages in
vivo (7, 12, 15, 31) and in vitro (25, 42, 45, 57, 58, 66) and elicit
CMI and DTH responses (7, 9, 12, 14, 15, 18, 46, 72). Several
reports indicate that M. ulcerans infections are also associated,
at least at some stage of the disease, with CMI and DTH (18,
27, 28, 33, 39, 43, 44, 50, 54, 56, 61, 67, 68, 70, 74), strongly
suggesting the existence of an intracellular phase in the life
cycle of M. ulcerans inside macrophages. It is therefore intrigu-
ing that M. ulcerans has been described as an extracellular
pathogen in humans and experimentally infected animals (1,
11, 12, 17, 26, 29, 33, 52), implying that this organism is an
exception among pathogenic mycobacteria (12).
The interpretation that M. ulcerans is an extracellular patho-
gen stems mainly from reports that BU tissues show predom-
inantly free bacilli in extensive necrotic acellular areas (8, 17,
20, 29, 35). Other arguments advanced in support of that in-
terpretation are that (i) M. ulcerans and mycolactone, under
some in vitro conditions, inhibit the phagocytic activity of mac-
rophages (1, 13, 55, 58) and (ii) M. ulcerans fails to grow within
macrophages in vitro (1, 58).
The observation that extracellular acid-fast bacilli (AFB)
predominate in necrotic areas devoid of cells has also led to the
concept that the total absence of, or only minimal, inflamma-
tion is typical of M. ulcerans infections (11, 17, 29, 33, 35).
Although such a histopathological pattern is a diagnostic hall-
mark of BU, it may not reflect the actual host-parasite inter-
actions at the active foci of infection in patients with BU,
interactions that so far have not been analyzed in detail. How-
ever, a recent publication (32) reported inflammatory infil-
trates with neutrophils and mononuclear cells in 92% of 78 BU
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specimens with AFB, but no description of the relative loca-
tions of bacilli and inflammatory cells was given. Additionally,
we have recently described the consistent occurrence of in-
flammatory infiltrates with neutrophils and macrophages in the
mouse model, with M. ulcerans bacilli colocalizing with the
phagocytic cells and extracellular bacilli in necrotic acellular
areas (51). Other, earlier investigators have reported bacilli
within macrophages in experimental M. ulcerans infections (21,
41, 59). In this context, it is worth recalling that the initial
description of BU noted large numbers of bacilli within phago-
cytes (43).
Because M. ulcerans infections are associated with CMI and
DTH responses, and because of our previous observations with
mice, we postulated that M. ulcerans would be an intracellular
pathogen with a phase of extracellular existence.
The objective of the present work is to clarify the lifestyle of
M. ulcerans by reevaluating M. ulcerans-phagocyte interactions
in BU tissues, mouse tissues, and cultured macrophages. One
advantage of the mouse footpad model is that it is possible to
systematically observe the entire lesion and surrounding
healthy tissues even in advanced infections. We complemented
these observations with in vitro studies involving the interac-
tions of M. ulcerans with mouse bone marrow-derived macro-
phages (BMDM) and with the macrophage cell line J774A.1.
Our results show that, in a considerable percentage of BU
biopsy specimens containing AFB and inflammatory infiltrates,
intramacrophage mycobacteria are present in the infiltrates at
the peripheries of the necrotic acellular areas. In this model of
infection, we also found that virulent mycolactone-producing
strains of M. ulcerans are efficiently phagocytosed by macro-
phages in vitro and in vivo, can be found within macrophages
during the entire course of infection, and grow intracellularly
within cultured macrophages. These data show that M. ulcer-
ans, like M. tuberculosis, is an intracellular parasite with phases
of extracellular and intramacrophage multiplication.
MATERIALS AND METHODS
BU biopsy specimens. We studied 24 paraffin-embedded biopsy specimens
from African patients with ulcerative or nonulcerative BU lesions, confirmed by
histopathological features and the presence of AFB, from the pathology archives
of the Armed Forces Institute of Pathology, Washington, DC. Serial sections of
the entire specimens were viewed under the Olympus BX61 light microscope
following staining with Ziehl-Neelsen stain (ZN; Merck, Darmstadt, Germany)
and hematoxylin (Merck) or methylene blue.
For the isolation of M. ulcerans from BU samples, the tissues (1 g) were
homogenized in 1 ml saline, decontaminated, and inoculated onto Lo¨wenstein-
Jensen medium. The inoculated tubes were incubated for up to 12 months at
33°C and were observed weekly. For detection of the RD1 gene cluster, primers
for esxA (Esat-6, 5-GACAGAACAGCAGTGGAATTTCG-3 and 5-CTTCT
GCTGCACACCCTGGTA-3) and esxB (Cfp-10, 5-TTTTGAAGAACGATGC
CGCTAC-3 and 5-TGACGGATGTTCGTCGAAATC-3) were used (48). “M.
liflandii” ITM04-3050 and M. ulcerans ITM00-1240 were used as positive and
negative controls, respectively.
Mycobacterial strains and preparation of inocula for experimental work. M.
ulcerans strains were selected based on different degrees of virulence in mice. M.
ulcerans 98-912 and 97-1116 are highly virulent, and strain 5114 is avirulent (51).
The origins and genetic and phenotypic characteristics of strains 98-912 and 5114
have been previously described in detail (51). Strain 5114 contains the RD1 gene
cluster (48) and does not produce mycolactones (47, 69). Strain 97-1116 pro-
duces mycolactones A and B (47), and we found it to lack the RD1 gene cluster,
as is typical of African strains (48). Strain 98-912 possesses the RD1 gene cluster
(48) and produces mycolactones A and B slightly different from those in African
strains (34). For the determination of the percentage of phagocytosis, M. tuber-
culosis H37Rv and M. bovis BCG Pasteur were used as controls. M. tuberculosis
possesses RD1, and M. bovis BCG lacks this gene cluster (6).
The M. ulcerans strains were grown on Lo¨wenstein-Jensen medium at 32°C for
approximately 2 months, recovered from slants, diluted in phosphate-buffered
saline to a final concentration of 1 mg/ml, and vortexed by using 2-mm-diameter
glass beads. The number of AFB in the inocula was determined by the method
of Shepard and McRae (62) using ZN. The final suspensions revealed more than
90% of the cells to be viable as assessed with the LIVE/DEAD BacLight kit
(Molecular Probes, Leiden, The Netherlands).
Animals. Eight-week-old female BALB/c mice were obtained from Charles
River (Barcelona, Spain) and were housed under specific-pathogen-free condi-
tions with food and water ad libitum.
Peritoneal model of infection. Mice were infected in the peritoneal cavity with
0.1 ml of M. ulcerans suspensions containing 7 log10 AFB of M. ulcerans strain
98-912, 97-1116, or 5114. Phosphate-buffered saline was used as a control. At
different time points after infection, four mice per group were sacrificed and
peritoneal cells were recovered for cytospin preparations by peritoneal lavage.
Cytospin preparations were fixed with 10% Formol in ethanol, stained with ZN,
and counterstained with Hemacolor (Merck).
Footpad model of infection. Mice were infected in the left hind footpad with
0.03 ml of suspensions containing 6 log10 AFB of M. ulcerans 98-912 or 97-1116.
The right hind footpad was used as a control.
Culture of murine BMDM and J774A.1 macrophage cell line. BMDM were
prepared as previously described (51). For AFB counting and light microscopy
analysis, BMDM were seeded in 24-well plates at a density of 5  105 cells/well;
for electron microscopy, BMDM were seeded in 6-well plates at a density of
3.5  106 cells/well. The plates were kept at 37°C in a 5% CO2 atmosphere.
Twelve hours before infection, macrophages were incubated at 32°C in a 5% CO2
atmosphere and maintained under these conditions thereafter.
Because BMDM survive in vitro for only a short time, the macrophage cell line
J774A.1 was used for longer experimental infections. The J774A.1 mouse mac-
rophage cell line was seeded in 12-well plates at a density of 2  105 cells/well
and incubated at 37°C for 12 h to allow macrophage adherence. Cells were then
washed with Dulbecco modified Eagle medium (DMEM) and incubated at 32°C
in a 5% CO2 atmosphere and maintained in these conditions thereafter.
Macrophage infectivity assays. Bacterial suspensions were further diluted in
DMEM to obtain the selected multiplicity of infection (MOI; bacterium/macro-
phage ratio). For the assessment of phagocytosis and of intramacrophage growth
of M. ulcerans, BMDM and J774A.1 cells were infected with the appropriate
number of bacilli and incubated for 4 h at 32°C in a 5% CO2 atmosphere and
then washed with warm Hank’s balanced salt solution to remove noninternalized
bacteria. For growth experiments, the macrophages were reincubated at 32°C in
DMEM for maximum periods of 8 and 15 days, respectively. At 7 and 10 days
after infection, J774A.1 cultures were supplemented with fresh medium by add-
ing 1 ml of DMEM per well.
Since the M. ulcerans strains used in this study were found to grow in DMEM
and to be susceptible to 20 g/ml of amikacin (data not shown), this concentra-
tion of amikacin (Sigma, St. Louis, MO) was added to the culture wells after
infection and kept during the whole period of the experiment to prevent extra-
cellular M. ulcerans growth (45, 57).
To evaluate the intramacrophage growth of M. ulcerans, AFB were counted as
follows: macrophages were lysed with 0.1% saponin (final concentration; Sigma),
the suspensions were homogenized with 2-mm glass beads, and the AFB were
counted (62). Monolayers were not washed previous to AFB counting to avoid
losing nonadherent or loosely adherent cells.
Cytological analysis. Adhesion of BMDM was carried out on 13-mm-diameter
plastic coverslips (Nunc, Naperville, IL) in 24-well plates. For cytological anal-
ysis, plastic coverslips were removed and the cells were fixed with 10% Formol in
ethanol, stained with ZN, and counterstained with hematoxylin. Cells were an-
alyzed under a light microscope, and digital images were captured by using an
Olympus DP70 camera (Hamburg, Germany).
To quantify dead macrophages, the trypan blue (Gibco, Paisley, United King-
dom) exclusion assay was employed. J774A.1 macrophages were carefully
scraped off by using a cell scraper, stained, and counted.
For ultrastructural studies, BMDM cultures were processed for electron mi-
croscopy as previously described (63) and viewed and photographed under a
Zeiss EM10 electron microscope (Hallbergmoos, Germany).
Histological studies. Human macrophages were labeled with the antibody
NCL-LN5 (Novocastra, Newcastle, United Kingdom) that specifically stains the
cytoplasm of histocytes and macrophages (5) or with an isotype control antibody.
Briefly, the tissue sections were deparaffinized with xylene, followed by sequen-
tial immersion in graded ethanol solutions and hydration. The sections were
microwave incubated for 15 min with a commercial antigen retrieval solution,
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citrate buffer heat-induced epitope retrieval (Labvision Corporation, Fremont,
CA). Endogenous peroxidase activity was blocked with 3% H2O2 for 10 min, and
primary antibody was added and incubated for 1 h. Slides were developed with
the Ultravision anti-polyvalent horseradish peroxidase ready-to-use detection
system (Labvision Corporation). For diaminobenzidene detection, slides were
incubated with the Ultravision large-volume diaminobenzidene substrate system
(Labvision Corporation).
Excised tissues of mouse footpads were fixed in 10% phosphate-buffered
formalin. Whole paws were decalcified (Thermo Shandon TBD-1; Runcorn,
United Kingdom) and embedded in paraffin. Longitudinal sections of the entire
paw were stained with ZN. For labeling of mouse macrophages, the specific
marker antibody F4/80 or an isotype control antibody was used, according to the
procedure referred to above for immunohistochemical staining. All digital im-
ages were captured by using an Olympus DP70 camera.
The present study was conducted under the guidelines and approval of the
Research Ethics Committee of the Life and Health Sciences Research Institute.
RESULTS
BU biopsy specimens show intramacrophage M. ulcerans
bacilli in inflammatory infiltrates. M. ulcerans has been de-
scribed as an extracellular parasite, an exception among patho-
genic mycobacteria. On the other hand, reports of CMI and
DTH responses to M. ulcerans infections (18, 27, 28, 33, 39, 43,
44, 50, 54, 56, 61, 67, 68, 70, 74) point to an intracellular
residence of M. ulcerans. To reevaluate this issue, we started by
performing histopathological analyses of BU tissues.
Nineteen specimens from the Armed Forces Institute of
Pathology collection from active cases of African BU were
selected based on the presence of AFB and the absence of
secondary infections. Serial sections were searched for inflam-
matory infiltrates and for the localization of AFB in the extra-
cellular and intracellular compartments. Among the 19 cases,
inflammatory infiltrates were observed in 15 (Table 1). This
result agrees with a recent report describing cellular inflam-
matory responses in a high percentage of BU cases (32).
Among the 15 specimens containing inflammatory cells, 8
showed intracellular bacilli (Table 1), as shown for 2 represen-
tative specimens (Fig. 1A to F). In addition, NCL-LN5 anti-
body demonstrated that M. ulcerans bacilli were present within
macrophages (Fig. 1C). The histopathological hallmark of BU,
extracellular bacilli, was found in all cases and was particularly
abundant in the necrotic acellular areas (Fig. 1B), while bacilli
colocalizing with inflammatory cells were found in the infil-
trates at the peripheries of the necrotic areas (Fig. 1A). Some
intracellular bacilli appeared as globus-like structures (Fig. 1F)
or within phagocytes undergoing apoptosis (Fig. 1E).
Detection of the gene cluster RD1 carried out with M. ul-
cerans strains from six of the studied BU specimens, with and
without detectable intracellular bacilli (Table 1), showed that
all these strains were RD1 negative as was previously found
with other M. ulcerans strains isolated from African patients
(48). This result suggests that there is no correlation between
the occurrence of intracellular bacilli and RD1.
Following experimental infections, M. ulcerans bacilli are
phagocytosed by resident macrophages in vivo and by BMDM
and J774A.1 macrophages in vitro. Murine peritoneal leuko-
cyte populations can be readily and precisely studied, and this
model proved useful in the elucidation of host interactions
with several species of mycobacteria (3, 53, 65). We have pre-
viously reported the recruitment of phagocytes to the perito-
neal cavity in response to inoculated M. ulcerans (51). There-
fore, we used this model to study the early interactions of
phagocytes and M. ulcerans.
Microscopic analyses revealed that for all the strains of M.
ulcerans tested (98-912, 97-1116, and 5114), bacilli were phago-
cytosed by resident macrophages and recruited neutrophils
after the first few hours postinfection, as shown in Fig. 2A for
strain 98-912. As previously described for experimental peri-
toneal infections caused by other mycobacteria (65), as well as
the livers of mice infected with Listeria monocytogenes (30) or
TABLE 1. Clinical data and histopathologic features evaluated for human biopsy specimens from patients with active BUa
Origin of specimen Clinical feature Extracellular AFB Inflammation Intracellular AFB RD1
Benin Nonulcerative    ND
Togo Nonulcerative    Negative
Benin Ulcer    ND
Democratic Republic of Congo Ulcer    Negative
Coˆte d’lvoire Ulcer    ND
Benin Nonulcerative    ND
Benin Nonulcerative    Negative
Coˆte d’lvoire Ulcer    ND
Democratic Republic of Congo Ulcer    ND
Democratic Republic of Congo Ulcer    ND
Democratic Republic of Congo Ulcer    ND
Benin Nonulcerative    ND
Benin Nonulcerative    ND
Benin Nonulcerative    Negative
Benin Nonulcerative    Negative
Democratic Republic of Congo Ulcer    ND
Democratic Republic of Congo Ulcer    ND
Benin Ulcer    ND
Benin Ulcer    Negative
Totalb 19 (100) 15 (79) 8 (42)
a , present; , absent; ND, not determined.
b Number of specimens with the indicated characteristic; numbers in parentheses are percentages of the total number of specimens examined.
VOL. 75, 2007 INTRAMACROPHAGE M. ULCERANS 979
 at Universiteitsbibliotheek G
ent on January 29, 2010 
iai.asm
.org
D
ow
nloaded from
 
Salmonella enterica serovar Typhimurium (60), we found that
neutrophils containing ingested bacilli were progressively
phagocytosed by macrophages so that these bacteria were
eventually taken up by macrophages.
As in our previous study (51), we consistently found intra-
cellular M. ulcerans in the subcutaneous tissue of mouse foot-
pads infected with M. ulcerans when the histological analysis of
the entire footpad was performed. Mycolactone-producing M.
ulcerans bacilli (strains 98-912 and 97-1116) were phagocytosed
by mononuclear phagocytes and neutrophils a few hours post-
inoculation (Fig. 2B) and throughout the entire experimental
period (Fig. 2B to G). The intramacrophage location of M.
ulcerans was confirmed by specific immunohistochemical label-
ing (Fig. 2E). Some infected macrophages contained high
numbers of packed clusters of bacilli, reminiscent of globi seen
in lepromatous leprosy. These structures were seen both within
distended macrophages (Fig. 2G) and free in the extracellular
compartment (Fig. 2F and G), probably following the lysis of
infected macrophages. Such clusters of AFB in BU have been
previously described (10, 43) and were also found by his-
topathological analysis of BU specimens included in the
present study (Fig. 1F). The occurrence of macrophages with
high numbers of packed bacilli is suggestive of intracellular
multiplication, as in the case of M. leprae infections. In the
advanced lesions, the central necrotic acellular areas with high
numbers of extracellular bacilli were prominent (Fig. 2F and
G), but in the boundary between these areas and the surround-
ing inflammatory infiltrates, clumps of extracellular bacilli were
found (Fig. 2F and G). The sizes of the clumps of free bacilli
grew as the distance from the limit of the infiltrated areas
increased (Fig. 2F and G), suggesting extracellular multiplica-
tion of M. ulcerans.
We then established an in vitro model of BMDM infection
at 32°C to study the interactions of M. ulcerans with primary
macrophages. Preliminary studies showed that macrophage vi-
ability, assessed by cell rounding, shrinkage, and detachment
(26), as well as by terminal deoxynucleotidyltransferase-medi-
ated dUTP-biotin nick end labeling staining (51), was compro-
mised at high MOIs when mycolactone-producing, cytotoxic
M. ulcerans strains were tested (not shown). An early cytotoxic
FIG. 1. Intracellular M. ulcerans bacilli are found in specific areas of biopsy specimens from BU patients. The two cases shown (A to C and
D to F) are representative of the human biopsy specimens showing inflammation and intracellular bacilli. (A) Extracellular bacilli are shown in
the necrotic acellular area of the lesion, and bacilli colocalizing with inflammatory cells were found in the peripheral infiltrate. (B) Detail of the
abundant extracellular bacilli in the central acellular area. (C) Specifically stained macrophages with internalized bacilli in the peripheral
inflammatory area. (D to F) High magnifications of the areas containing inflammatory infiltrates colocalizing with AFB show intracellular bacilli
associated with destruction of phagocytes (E) and intracellular, as well as extracellular, globus-like structures (F). Histological sections were stained
with ZN and counterstained with hematoxylin or methylene blue. NCL-LN5 antibody was used to specifically label human macrophages.
Magnifications, 250 (A) and 1,250 (B, C, D, E, and F).
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effect on macrophages was also described for M. tuberculosis
and M. marinum at high MOIs, being absent at an MOI of 1:1
or lower (25, 42, 57). We therefore tested lower MOIs and
found that at an MOI of 1:1 to 1:3, the early cytotoxic effect
was abolished. Microscopic analysis showed that M. ulcerans
98-912, 97-1116, and 5114 were internalized by macrophages as
early as 4 h after infection at a 1:1 MOI, as shown in Fig. 3A
for strain 98-912 (see also Fig. 4E for quantitative data). Ul-
FIG. 2. M. ulcerans is phagocytosed by macrophages and neutrophils in vivo following experimental infections. (A) Cytospin preparations of
mouse peritoneal leukocytes 6 h after inoculation with 7 log10 AFB of M. ulcerans 98-912, stained with ZN and counterstained with Hemacolor.
(B to G) Mouse footpads infected subcutaneously with 6 log10 AFB of M. ulcerans 98-912, collected 24 h (B) and 15 (C to E) and 28 (F and G)
days after infection. (A and B) Bacilli inside neutrophils and macrophages (arrows) early after infection. (C and D) Extracellular bacilli in the
necrotic acellular center of the infection focus (shown in high magnification in panel D), surrounded by inflammatory cells with intracellular bacilli.
(E) Higher magnification of the peripheral area with inflammatory infiltrates shows specific immunohistochemical staining of a macrophage with
internalized bacilli. (F and G) Central acellular necrotic areas and peripheral inflammatory infiltrates in advanced lesions, with both intramac-
rophage and free bacilli, some packed in globus-like structures with intracellular (arrowheads) or extracellular (white asterisks) locations.
Histological sections were stained by ZN and counterstained with methylene blue or hematoxylin. The F4/80 antibody was used to specifically label
murine macrophages. Magnifications, 1,250 (A, B, D, and E), 550 (C and F), and 1,000 (G).
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trastructural analysis confirmed the presence of intramacroph-
age M. ulcerans, including the more-cytotoxic strain 98-912
(Fig. 3B and C). Bacilli were present within spacious (Fig. 4A)
or tight (Fig. 4B and D) phagosomes, as described previously
for other mycobacteria (4). Quantitative assessment of phago-
cytosis of M. ulcerans by BMDM showed that after 4 h at an
MOI of 1:1, 26.3%  7.5% of the inoculum was internalized
for the mycolactone-negative strain 5114; 22.1%  4.2% and
29.9% 8.7% of the bacteria were within macrophages for the
mycolactone-producing strains 98-912 and 97-1116, respec-
tively (Fig. 4E). The phagocytosis index of M. ulcerans at an
MOI of 1:1 in the macrophage murine cell line J774A.1 was
found to be similar to that in BMDM, as shown for strain
97-1116 (Fig. 4E). Similar values were found for M. tuberculosis
H37Rv and M. bovis BCG (30.3% 11.4% and 24.9% 5.7%,
respectively). These results suggest that RD1-positive and
RD1-negative mycobacteria behave similarly regarding phago-
cytosis by BMDM at low MOIs, since M. tuberculosis H37Rv
and M. ulcerans 5114 and 98-912 are RD1 positive (6, 48) and
M. bovis BCG (6) and M. ulcerans 97-1116 (data not shown)
are RD1 negative.
Taken together, these results show that soon after experi-
mental infection with M. ulcerans, irrespective of the cytotox-
icity of the clinical isolate, bacilli are phagocytosed by cultured
macrophages as well as by resident macrophages and recruited
neutrophils in vivo. Furthermore, intramacrophage bacilli are
consistently seen in the inflammatory infiltrates at the periph-
eries of the necrotic acellular areas where extracellular bacilli
accumulate.
M. ulcerans proliferates within cultured macrophages. Fol-
lowing our observation of intramacrophage M. ulcerans both in
vitro and in vivo, we evaluated the intracellular growth of M.
ulcerans within BMDM by counting AFB. Amikacin was used
to prevent extracellular bacterial multiplication (45, 57). At an
MOI of 1:1, we found a 0.6 log10 increase in intracellular AFB
counts at 8 days for the mycolactone-negative strain 5114 and
the mycolactone-producing strain 97-1116 (Fig. 5A). However,
for the most cytotoxic strain, 98-912 (51), bacterial counts did
not increase when the same MOI was used (Fig. 5A). This is
due to the macrophage damage induced by M. ulcerans 98-912,
as shown by the necrotic alterations in most infected macro-
phages (Fig. 3C). Necrotic macrophages lose cytoplasmic
membrane integrity (75), permitting access of amikacin to ba-
cilli. However, at an MOI of 1:3, a significant growth of 0.6
log10 was observed over the 8-day experimental period (Fig.
5B), showing that this cytotoxic strain also proliferates inside
macrophages when early damage to the macrophages is pre-
vented.
M. ulcerans lyses infected macrophages after an initial phase
of intracellular proliferation. We then questioned whether or
not the continuous intracellular growth of a cytotoxic M. ulcer-
ans strain in macrophages would result in the lysis of the
infected cells due to the activity of mycolactone, leading to the
shedding of bacilli. To address this question, we infected
J774A.1 macrophages, which can be cultured for 15 days, with
the mycolactone-producing M. ulcerans strain 97-1116 or the
mycolactone-negative strain 5114 at different MOIs in the
presence of amikacin.
As with infected BMDM, we found that both the 97-1116
and 5114 M. ulcerans strains are phagocytosed and grow inside
FIG. 3. Intracellular M. ulcerans bacilli are found in mouse BMDM
infected in vitro. BMDM were infected with M. ulcerans 98-912 (MOI,
1:1). (A) Coverslips were removed 4 h postinfection, and the cells were
washed, stained with ZN, and counterstained with methylene blue. Mi-
croscopic analysis shows bacilli inside macrophages (arrowheads). Mag-
nification, 1,250. (B) Electron microscopy of BMDM infected for 4 h
with M. ulcerans 98-912 and photographed 4 days later, showing bacilli
inside an intact macrophage (arrowheads). Bar 1 m. (C) Six bacilli are
seen within a lysing macrophage; one bacillus is inside the nucleus (N),
which has ruptured nuclear membranes. This macrophage shows features
typical of necrosis (75), namely, rupture of the cytoplasmic and nuclear
membranes, condensation of chromatin, swelling and disruption of mito-
chondria, and loss of the normal density of the cytosol. Bar  1 m.
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J774A.1 macrophages (Fig. 5C and D). With strain 97-1116 at
an MOI of 1:1, the bacterial load increased, reaching 5.68 
0.11 log10 AFB by day 10 postinfection, when an arrest in
bacterial proliferation was observed (Fig. 5C). At this time
point, the number of dead macrophages had increased from
4.35  0.16 log10 at time zero to 5.29  0.15 log10 (an 8.7-fold
increase). With strain 5114 at an MOI of 1:1, the bacterial load
at 10 days was 5.61  0.10 log10 AFB, with an increase in
FIG. 4. M. ulcerans is found within macrophage phagosomes, and all tested strains are phagocytosed by BMDM at an MOI of 1:1, irrespective
of their cytotoxic activity. For electron microscope studies (A to D), BMDM were infected for 4 h with M. ulcerans 98-912 (MOI, 1:1) and sampled
4 days after infection. Intracellular bacilli can be found within spacious (A) or tight (B) phagosomes. Bars  0.5 m. PM, phagosomal membrane.
(C) Detailed image of the cell envelope of extracellular bacilli. The typical layers of mycobacterial envelopes (64) are visible, namely, the
cytoplasmic membrane (CM) covered by the cell wall with an innermost electron-dense peptidoglycan layer (PGL), an intermediate electron
transparent layer (ETL), and an outer electron-dense layer (OL). Bar  0.1 m. (D) High magnification of the bacillary envelope at the zone
labeled with an arrow in panel B, showing the same envelope layers shown in panel C plus a tightly apposed phagosomal membrane outside the
OL. Bar  0.1 m. (E) BMDM (solid bars) were infected for 4 h with M. ulcerans 5114, 97-1116, or 98-912 (MOI, 1:1) or, for comparison, with
M. tuberculosis H37Rv or M. bovis BCG (MOI, 1:1). To assess the phagocytosis of M. ulcerans by a different macrophagic cell, J774A.1 cultures
were infected with M. ulcerans 97-1116 as described for BMDM (striped bar). Student’s t test for the rates of phagocytosis gave nonsignificant P
values. Results are from one representative experiment out of three independent experiments.
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macrophage mortality of only 1.3-fold; bacterial growth con-
tinued, reaching 5.85  0.17 log10 AFB by day 15, when mac-
rophage mortality increased only 1.6-fold. When the higher
MOI of 3:1 was tested, the cytotoxic load of strain 97-1116 was
achieved at day 3, when the number of AFB reached 5.48 
0.17 log10 (Fig. 5D) and the number of dead macrophages was
5.26  0.12 log10 (an 8.1-fold increase). At this MOI, strain
5114 reached 5.58  0.13 log10 AFB at day 3, when macro-
phage mortality increased only 1.2-fold; growth continued,
reaching 6.19  0.09 log10 AFB by day 15. At this time point,
the number of dead macrophages had increased only 3.5-fold.
In contrast, with strain 97-1116 at the same MOI, the number
of dead macrophages had increased 12.6-fold by day 15, with a
lower bacterial load (5.54  0.14 log10 AFB).
Altogether, these findings show that after an initial phase of
intracellular proliferation, cytotoxic M. ulcerans becomes ac-
cessible to amikacin, suggesting that lysis of infected macro-
phages occurs when a certain bacterial load is reached. In vivo,
intracellular growth of mycobacteria occurs by cycles of mul-
tiplication in individual macrophages followed by their lysis,
egress of replicated bacilli, and entry of these bacilli into new
macrophages where the growth cycle is repeated (25). The use
in our in vitro experiments of amikacin to prevent extracellular
proliferation of M. ulcerans (45, 57) blocks the spreading of the
infection from lysed infected macrophages to healthy macro-
phages, resulting in an underestimation of the capacity of cy-
totoxic M. ulcerans to grow in cells.
DISCUSSION
The prevailing concept is that M. ulcerans is an extracellular
pathogen in humans and experimentally infected animals (1,
11, 12, 17, 26, 29, 33, 52). This concept represents an exception
among pathogenic mycobacteria (12) and is based mainly on
the description of absent or minimal inflammation as a typical
feature of M. ulcerans infections and on the fact that BU
tissues show predominantly free bacilli in extensive necrotic
acellular areas (8, 17, 20, 26, 29, 35). In our previous study, we
demonstrated with the mouse model of BU that inflammatory
infiltrates containing bacilli are consistently present at the pe-
ripheries of necrotic acellular areas. From this observation, we
concluded that studies directed toward the evaluation of the
interactions between phagocytes and M. ulcerans in human
infections were justified (51). We have shown here that among
tissue specimens from 19 BU patients, 8 of 15 specimens with
inflammatory exudates and AFB revealed intramacrophage M.
ulcerans in the inflammatory cells at the peripheries of the
extensive necrotic acellular areas. This picture clearly parallels
the scenario we described for footpads of mice with experi-
mental BU. Intramacrophage M. ulcerans bacilli were readily
found in the mouse model, because the entire lesion could be
evaluated histopathologically. In specimens from BU patients,
however, this phenomenon was not often appreciated because
inflammatory exudates and bacilli were not always represented
in the tissue fragments. BU lesions are usually extensive, and
the chances that a fragment of tissue will fail to include areas
of inflammatory infiltrates and bacilli are high. In many in-
stances, intramacrophage M. ulcerans bacilli were found only
after multiple consecutive sections had been evaluated.
Another argument has been put forward in favor of the
concept that M. ulcerans is an extracellular pathogen: under
some in vitro conditions, M. ulcerans and mycolactone inhibit
the phagocytic activity of macrophages (1, 13, 55, 58). Extend-
ing previous data from our group (51), we now show quanti-
tatively that mycolactone-producing M. ulcerans strains are
efficiently ingested in vivo as well as by mouse macrophages in
vitro at rates comparable to those for a mycolactone-negative
M. ulcerans strain and for M. tuberculosis and M. bovis BCG.
Our present results suggest that previous data showing inhibi-
FIG. 5. M. ulcerans clinical isolates grow within mouse BMDM and
J774A.1 macrophages before inducing cell lysis and becoming extra-
cellular. All macrophage infections were performed in the presence of
amikacin. (A and B) BMDM were infected for 4 h at an MOI of 1:1
with M. ulcerans 5114 (closed circles), 97-1116 (closed triangles), or
98-912 (closed squares) (A) or at an MOI of 1:3 (open squares) with
M. ulcerans 98-912 (B). At an MOI of 1:1, M. ulcerans 5114 and
97-1116, but not M. ulcerans 98-912, proliferate inside macrophages for
a period of 8 days. At a lower MOI, the early cytotoxic effect of M.
ulcerans 98-912 is reduced and intracellular growth was detected. Sta-
tistically significant differences between results at day 0 and day 4 or 8,
as evaluated by Student’s t test, are labeled with double asterisks (P 
0.01) or triple asterisks (P  0.001). (C and D) J774A.1 cells were
infected for 4 h with the mycolactone-positive M. ulcerans strain 97-
1116 (triangles) or the mycolactone-negative strain 5114 (circles) at an
MOI of 1:1 (C) or 3:1 (D) for a period of 15 days. Panels C and D show
the numbers of AFB/well, demonstrating that M. ulcerans 97-1116
grows inside macrophages before inducing their death and becoming
extracellular as indicated by an arrest in bacterial growth (at day 3 for
an MOI of 3:1 and day 10 for an MOI of 1:1). In contrast, strain 5114
at both MOIs grew continuously until the end of the experiment.
Statistical significance was calculated by using Student’s t test, com-
paring the results at each time point with those of the previous time
point, and significant differences are labeled with a single asterisk (P
0.05) or double asterisks (P  0.01). Results are from one represen-
tative experiment out of two independent experiments.
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tion of phagocytosis of M. ulcerans in vitro (1, 55, 58) are
explained by the use of high MOIs resulting in early mycolac-
tone-induced damage to the macrophages (26). The only pre-
vious study using low MOIs (13) concluded that M. ulcerans
bacilli “were efficiently captured by RAW264.7 macrophages,
bone marrow-derived macrophages, and the dendritic cell line
FSDC after a 3 h contact,” showing only a partial, dose-de-
pendent inhibition of the phagocytosis of wild-type M. ulcerans
compared to that of a mycolactone-negative isogenic mutant.
These findings and our results indicate that the presence of
extracellular M. ulcerans in infectious foci is not due to the
blockage of phagocytosis and explain the persistent occurrence
of intramacrophage M. ulcerans in infected tissues. A recent
publication on mouse intradermal M. ulcerans experimental
infection (13) reports intracellular bacilli primarily within neu-
trophils and rarely in macrophages and only in the initial stages
of the infection. Note, however, that a few early studies did
report intramacrophage bacilli in experimental (21, 41, 59) and
human (43) M. ulcerans infections.
The presence of M. ulcerans within macrophages in the focus
of infection is not evidence that in vivo this mycobacterium is
primarily an intracellular parasite. However, using in vitro
models of macrophage infection, we show that M. ulcerans
multiplies intracellularly in macrophages, as is the case for the
M. ulcerans-related intracellular parasites M. marinum and M.
tuberculosis (25, 42, 45, 57, 58, 66). Previous attempts to grow
M. ulcerans within mammalian macrophages were unsuccessful
(1, 58) due to the cytotoxicity of bacilli for macrophages at the
high MOIs used (10:1 to 20:1). We avoided this early cytotoxic
effect by using MOIs of 1:1 to 1:3, as previously done with M.
tuberculosis and M. marinum (25, 42, 57). Our data show for
the first time that virulent, mycolactone-producing strains of
M. ulcerans grow inside mammalian macrophages at 32°C.
It would be intuitive to expect intracellular pathogens to
have low direct cytotoxicity so that no damage would be im-
parted to the host cells. Indeed, it has been considered that one
of the characteristics of intracellular pathogens is low cytotox-
icity (37) and that cytokines produced locally by immune cells
would be responsible for mycobacterium-associated cell de-
struction as seen in pulmonary tuberculosis (14, 22). However,
it is becoming progressively evident that intracellular parasites
can directly lyse macrophages to exit the cell efficiently after
termination of the intracellular proliferation phase and pro-
ceed to infect other cells in the same host (extending the
infection) or to pass to a new host (spreading the disease) and
that direct microbial cytotoxicity is a mechanism that promotes
cell lysis. In fact, it is known that many intracellular pathogens,
including M. tuberculosis and M. marinum, have direct cytotox-
icity toward professional and occasional phagocytes in vivo and
macrophages in vitro (19, 24, 25, 38, 42, 57). In addition, it has
been reported that several intracellular parasites, including not
only M. ulcerans-related mycobacteria (14, 25, 31) but also
Legionella pneumophila, Salmonella spp., and Shigella spp. (2,
40, 49, 60), also use cytotoxic mechanisms to lyse infected
macrophages at the end of their life cycles within the host cell,
thus becoming extracellular.
The consequences of the potentially conflicting features of
an intracellular lifestyle and cytotoxicity would be minimized if
M. ulcerans orchestrated a pattern of transcriptional control of
gene expression to turn off the synthesis of mycolactone during
intramacrophage growth. The genes involved in mycolactone
synthesis would later be switched on, resulting in the lysis of
the infected cells and egress of fully replicated bacilli. It has
been reported for infections with Salmonella spp. (40) and
Legionella pneumophila (2) that the pathogen machinery re-
sponsible for the lysis of host cells is turned off after the entry
of the pathogen into the macrophage and expressed only at the
end of an intramacrophage multiplication phase. Our results
showing that multiplication of M. ulcerans at different MOIs
within J774A.1 macrophages yields similar maximal bacterial
loads and induces similar macrophage viability losses, although
at different times, are compatible with the hypothesis of a
temporal switching off of mycolactone synthesis within macro-
phages.
The above-described observations showing that several
pathogens are able to reconcile cytotoxicity with intracellular
parasitism are in accordance with the concept that low cyto-
toxicity is a conditional rather than an absolute characteristic
of intracellular parasites (37).
In the mouse footpads and in BU tissues from humans,
extracellular bacilli colocalized with inflammatory cells but
were more abundant in the acellular necrotic areas. The pres-
ence of extracellular bacteria is compatible with intracellular
parasitism. Accumulation of extracellular bacilli in necrotic
areas, following the lysis of macrophages infected with intra-
cellular mycobacteria, has been previously reported for human
(31) and murine (36, 73) pulmonary tuberculosis, for human
skin lesions due to M. haemophilum (17), and for animals
infected with M. marinum (21, 25).
Our observation of progressive enlargement of the clumps of
extracellular AFB away from the areas of colocalization with
inflammatory cells suggests that there is extracellular growth of
M. ulcerans following the shedding of the bacilli from lysed,
infected macrophages. Taking into consideration this observa-
tion and the results showing that M. ulcerans bacilli (i) are
efficiently phagocytosed by mouse macrophages in vivo and in
vitro, (ii) are present inside macrophages in mouse footpad
and peritoneal infections and in BU tissues, and (iii) grow
within cultured macrophages, we propose that the growth of
M. ulcerans would take place, in a manner similar to that of M.
tuberculosis, by both intracellular and extracellular multiplica-
tion in distinct areas of the lesion (14, 31).
According to our model, some of the bacilli shed from lysing
macrophages would be taken up by resident macrophages and
by monocytes that are continuously attracted to the infectious
foci (51) and resume intracellular growth. This continuous
intracellular multiplication at the areas of inflammatory infil-
trates in active, progressing infections depends on the perma-
nent availability of resident macrophages and incoming mono-
cytes as host cells (51). Our interpretation is that this focus of
intramacrophage M. ulcerans residence and multiplication at
the peripheries of the necrotic areas promotes the progression
of the lesion by the invasion of healthy tissues and explains the
occurrence of CMI, DTH, and granulomatous responses re-
ported in murine and human M. ulcerans infections (18, 27, 28,
33, 39, 43, 44, 50, 54, 56, 61, 67, 68, 70, 74). In contrast, the
extracellular bacilli abundant in the central necrotic acellular
areas may be ultimately eliminated in the slough of necrotic
tissue when the lesion becomes ulcerative, as is the case for
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extracellular M. tuberculosis in the necrotic caseous foci in
human pulmonary tuberculosis (31).
In conclusion, our results showing the uptake of M. ulcerans
by macrophages in experimentally infected mice and in vitro,
the presence of intramacrophage bacilli in inflammatory infil-
trates of M. ulcerans-infected tissues, and the multiplication of
bacilli within cultured macrophages indicate that this mycobac-
terium fulfils the essential features for classification as an in-
tracellular parasite like the other pathogenic mycobacteria.
This interpretation is further supported by the reported pro-
tective CMI and DTH responses in mouse and human M.
ulcerans infections and may have value for the design of novel
prophylactic and therapeutic approaches for BU.
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